The production of cellular therapies requires the optimization of four steps: first, isolating and culturing cells that can be readily obtained from a patient in a non-invasive fashion. Second, the reprogramming of these cells into a pluripotent state. Third, the directed differentiation of those patient-specific pluripotent cells into the cell type relevant to their disease. And, fourth, techniques for repairing any intrinsic disease-causing genetic defects and transplantation of the repaired, differentiated cells into the patient. Notably, these disease-relevant patient cells can also be used for in vitro disease modeling which may yield new insights into disease mechanisms and drug discovery.
Cells, Free Full-Text
IJMS, Free Full-Text
Robust generation of hepatocyte-like cells from human embryonic
Feeder-independent culture protocol – EDTA splitting - StemBook
Stem cells: past, present, and future
Imaging transplanted stem cells in real time using an MRI dual
Commercialization, IPR, and Market of Stem Cell Products
Protocol for directed differentiation of human pluripotent stem
Liver development - StemBook - NCBI Bookshelf
Figure 1, The steps of regenerative medicine. - StemBook - NCBI
Differential role of natural killer group 2D in recognition and
Regenerative Medicine SanBio - Official Site
The two strategies of stem cell application in regenerative
Pluripotent Stem Cell Culture Scale-Out - Assay Guidance Manual
Is Regenerative Medicine Ready for Prime Time in Diabetic